D05 - Focus the Spotlight on JDRF: An Update on Key Initiatives in T1D Research

Sunday, August 6, 2023

9:45 AM – 10:30 AM CT

Location: Room 370

CE/CME Hours: 0.75

Collaborating Organization:

CE/CME Hours: .75
Pharmacology Hours: 0.0
Activity Type: Knowledge-based
UAN: JA4008258-0000-23-181-L01-P
CHES/MCHES: .75

JDRF is the leading global organization funding type 1 diabetes research, driven by the vision of a world without type 1 diabetes. JDRF is dedicated to improving lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent, and treat type 1 diabetes and its complications. JDRF is currently supporting over 500 active grants in the United States and around the world. In this session, attendees will be introduced to current investments in emerging technologies, adjunctive therapies, novel behavioral health initiatives, and JDRF’s commitment to health equity.

Invited Presenter(s)

Sanjoy Dutta, PhD

Chief Scientific Officer
JDRF

Disclosure(s): No financial relationships to disclose

Slides

Moderator(s)

Anastasia Albanese-O'Neill, PhD, APRN, CDCES (she/her/hers)

Director, Community Screening and Clinical Trial Education
JDRF International
Gainesville, Florida

Disclosure(s): Insulet: Employment (Terminated, November 30, 2021); JDRF International: Employment (Ongoing); Tandem Diabetes Care: Employment (Terminated, November 30, 2021)